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Abstract
Introduction The generic metabolomics data processing
workflow is constructed with a serial set of processes
including peak picking, quality assurance, normalisation,
missing value imputation, transformation and scaling. The
combination of these processes should present the experi-
mental data in an appropriate structure so to identify the
biological changes in a valid and robust manner.
Objectives Currently, different researchers apply differ-
ent data processing methods and no assessment of the
permutations applied to UHPLC-MS datasets has been
published. Here we wish to define the most appropriate
data processing workflow.
Methods We assess the influence of normalisation,
missing value imputation, transformation and scaling
methods on univariate and multivariate analysis of
UHPLC-MS datasets acquired for different mammalian
samples.
Results Our studies have shown that once data are fil-
tered, missing values are not correlated with m/z, retention
time or response. Following an exhaustive evaluation, we
recommend PQN normalisation with no missing value
imputation and no transformation or scaling for univariate
analysis. For PCA we recommend applying PQN normal-
isation with Random Forest missing value imputation, glog
transformation and no scaling method. For PLS-DA we
recommend PQN normalisation, KNN as the missing value
imputation method, generalised logarithm transformation
and no scaling. These recommendations are based on
searching for the biologically important metabolite features
independent of their measured abundance.
Conclusion The appropriate choice of normalisation,
missing value imputation, transformation and scaling
methods differs depending on the data analysis method and
the choice of method is essential to maximise the biolog-
ical derivations from UHPLC-MS datasets.
Keywords UHPLC-MS  Metabolomics  Random
forest  KNN  PQN normalisation  Glog transformation
1 Introduction
The application of Ultra High Performance Liquid Chro-
matography-Mass Spectrometry (UHPLC-MS) to acquire
non-targeted metabolomics data is increasing in fre-
quency. In 2014, there were 507 published papers in the
12 month period applying this instrumental platform as
defined in PubMed compared to 12 and 179 in 2005
and 2010, respectively (search terms present in all
fields = ‘metabolomics’ and ‘liquid chromatography’ and
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‘mass spectrometry’). Following the acquisition of three-
dimensional raw data (m/z vs. retention time vs. response),
the first process to convert this raw data to biological
knowledge is peak picking (or deconvolution) to align and
integrate data across multiple samples. Software such as
XCMS (Smith et al. 2006) and mzMine (Katajamaa et al.
2006) are freely available and commonly applied. The
resulting data matrix is typically constructed with thou-
sands of ‘metabolite features’ (m/z-retention time pairs)
and tens-to-thousands of samples. Prior to univariate and
multivariate data analysis this data matrix typically
undergoes a number of processes including quality control
(Dunn et al. 2011), missing value imputation, normalisa-
tion, scaling and transformation; here we will define this
as ‘data processing’ and the processes applied can follow
a specific workflow dependent on a number of factors
including the structure of the data acquired and the sub-
sequent data analysis techniques applied. A range of
tools [e.g. MetaboAnalyst (http://www.metaboanalyst.ca/)],
workflows [e.g. Galaxy-M (https://github.com/Viant-Meta
bolomics/Galaxy-M; Davidson et al. 2016) and Work-
flow4Metabolomics (Giacomoni et al. 2015)] and R
packages [e.g. mixOmics; http://mixomics.qfab.org] are
available to perform data processing. A random selection
of 51 papers (10 % of all papers) published in this area in
2014 was investigated to define the different processing
methods applied; SI1 lists the methods applied for nor-
malisation, missing value imputation, data transformation
and scaling. It is clearly evident that no single processing
workflow is applied across the metabolomics community.
Interestingly, a number of papers do not even define which
processing methods were applied.
Variation in the measured response unrelated to the
biological differences between samples can be observed in
studies analysing tens-to-thousands of samples. These
sources of variation include small changes in volume
applied during sample preparation and sample injection
and in instrument performance (changes in ionisation, ion
transfer and detector efficiency). Normalisation is applied
to correct for these unwanted peak intensity differences and
to stabilise the variance within the dataset. Normalisation
can be performed with or without applying an internal
standard as a reference to calculate observed analytical
errors. Normalization methods that are not based on
internal standards often apply the sum, mean or the median
of the responses of all metabolites across a sample as a
normalization factor (Xia and Wishart 2011; Martucci et al.
2014; Kohl et al. 2012). However, some of these approa-
ches (sum and mean) can introduce artificial correlations in
the data in the case of large differences between the groups
of samples in one or a few metabolites (Dieterle et al. 2006;
Li et al. 2015). Probabilistic quotient normalisation (PQN)
(Dieterle et al. 2006) was developed to reduce this effect
and has successfully been applied for normalization in
many metabolomics studies (Hrydziuszko and Viant 2012;
Davies et al. 2014; Cottet et al. 2014). Different methods
applying internal standards have been developed (De
Livera et al. 2012). Other methods applying internal stan-
dards for UHPLC-MS (Sysi-Aho et al. 2007; Waybright
et al. 2006) and GC–MS (Dunn et al. 2008b; Biais et al.
2009) for different biological samples have been investi-
gated and reported.
Missing values in metabolomics datasets can be observed
for three reasons: (1) metabolite is detected in one sample but
is not present at any concentration in another sample; (2)
metabolite is present in a sample but at a concentration less
than the analytical method’s limit of detection, and (3)
metabolite is present in a sample at a concentration greater
than the analytical method’s limit of detection but the data
processing software has not detected and reported the
metabolite. Some software apply gap filling algorithms
(Scheltema et al. 2011; Pluskal et al. 2010) though the
majority of software do not apply these algorithms, including
XCMS which is predominantly applied by the metabolomics
community (in the period between April 2015 and March
2016 the package XCMSwas downloaded 20,798 times from
6469 different IPs (https://bioconductor.org/packages/stats/
bioc/xcms.html). Missing value imputation (MVI) is applied
to logically replace missing values with a non-zero value
while maintaining the data structure. This approach is pri-
marily applied in multivariate analysis which typically oper-
ates most robustly with a dataset not containing missing
values, though one example where missing values can be
present is Bayesian PCA where missing value imputation is
performed as part of the algorithm. Rubin identified three
types of missing value occurrences (Rubin 1976): data can be
missing completely at random (MCAR) when the missing-
ness is unrelated to any observedvariable or response,missing
at random (MAR) when the missing-ness is related to one or
more observed variables but not to the response, and missing
not at random (MNAR)when themissing-ness is related to the
response itself. Therefore the distribution of missing values
can be random or systematic and in both cases the cause may
be biological or technical (Little 1998;Hrydziuszko andViant
2012). For example, if one class of samples does not contain a
metabolite that is present in another class of samples, the
missing values in the dataset aremost probably occurring for a
biological reason and can be defined asMNAR. However, if a
metabolitewhich is present in the sample is not detected in the
majority of or all samples then this ismost probably a result of
the metabolite concentration being lower than the analytical
methods’ limit of detection; themissing values are a result of a
combination of biological and technical issues and therefore
themissing value can be accounted asMNAR.Another source
of missing values caused by technical reasons are errors
associated with peak picking software where the peak is
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present but the peakobserved in the rawdata is not reported, in
this case the missing value can be accounted as MCAR.
A number of different missing value imputation (MVI)
methods are available. These include small value replace-
ment (SV) (Xia and Wishart 2011), mean replacement (MN)
(Steuer et al. 2007), median replacement (MD) (Steuer et al.
2007), k-nearest neighbour (KNN) (Steuer et al. 2007;
Troyanskaya et al. 2001), Bayesian PCA (BPCA) (Nya-
mundanda et al. 2010; Xia and Wishart 2011), multivariate
imputation by chained equation MICE (van Buuren and
Groothuis-Oudshoorn 2011) and Sangster’s method (Sang-
ster et al. 2007). As the missing value imputation affects all
of the following steps of the data processing and analysis
pipeline it is extremely useful to identify the most appropriate
method to apply in order to obtain the most robust results.
Hrydziuszko and Viant (2012) have compared different
commonly used missing value imputation methods for direct
infusion Fourier transform ion cyclotron resonance mass
spectrometry (DI FTICR-MS). Similarity between outcomes
produced by different missing value imputation methods and
imputation performance were evaluated and the results
showed that KNN was the most robust missing value
imputation method for DIMS metabolomics data. Gromski
et al. (2014) published a study which explored the effects of
different MVI methods on GC–MS datasets, evaluating their
impact on classification performance in unsupervised and
supervised multivariate models. That study concluded that
Random Forest (RF) should be favoured as a MVI method.
The application of MVI has also been investigated in tran-
scriptomics and proteomics. Troyanskaya et al.(2001)
examined the impact of missing values on statistical
parameter evaluation for genomics, while the effect of the
handling of missing values on univariate and multivariate
statistics was studied by Scheel et al.(2005) for genomics and
Pedreschi et al.(2008) for proteomics. While the first study
recommended the use of an in-house package for MVI in
transcriptomics, the second concluded that BPCA was the
most efficient method for proteomics. A detailed investiga-
tion of how missing value imputation methods influence LC–
MS metabolomics datasets and corresponding data analysis
results has not been published to our knowledge.
Element-wise transformations of the data are carried out
to correct for any data heteroscedasticity and any skewed
distribution that is present. Transformation methods most
frequently applied include logarithmic modifications [gen-
eralised logarithm (glog) or natural logarithm (nlog)] (Yau
et al. 2014; Lopez-Sanchez et al. 2015; van der Kloet et al.
2013), often adding a constant value to the argument in
order to cope with near-zero values (Mak et al. 2014).
Scaling is performed to adjust for differences in fold change
between metabolites which may be caused by large differ-
ences in the variation of the measured responses; however,
the use of a scaling factor reduces such large differences to a
relative value which is not dependant on the absolute
abundance. A range of scaling methods has been applied in
metabolomics including autoscaling (Jackson 1991), Pareto
scaling (Eriksson et al. 1999), range scaling (Smilde et al.
2005) and VAST scaling (Keun et al. 2003). Different
scaling and transformation methods have been assessed for
GC–MS datasets (van den Berg et al. 2006) and a compar-
ison between autoscaling and Pareto scaling has been per-
formed for a single UHPLC-MS dataset (Masson et al.
2011). These studies concluded that autoscaling and range
scaling were the most appropriate scaling method to apply in
GC–MS metabolomics recommending these methods when
metabolite abundance and fold change are not expected to
influence the statistical multivariate model.
A number of papers investigating different data pro-
cessing procedures have been published. Bijlsma et al.
(2006) assessed different scaling, univariate analysis and
multivariate analysis procedures in order to identify lipi-
domic biomarkers applying LC–MS. All data were nor-
malised by reference to an internal standard as the only
method assessed and only two scaling methods were tested
(autoscaling and mean centering). The study produced a
reproducible workflow for PLS-DA validation in order to
detect low abundance biomarkers.
As detailed above a range of different data processing
methods are applied but no systematic assessment of the
integrated application of each of these methods has been
published for UHPLC-MS metabolomics datasets. Here we
assess different data processing methods, both singularly and
combined, to define the data processing methods that are
optimal for univariate (Mann–Whitney U test) and multi-
variate analysis (PCA, PLS-DA) methods and identify those
data processingmethods that are not appropriate for providing
robust biological knowledge fromUHPLC-MS data acquired
for serum/plasma. We will define the impact of different data
processing methods and formulate an appropriate ‘fit-for-
purpose’ data processingworkflow from these data. Itmust be
noted that this approach does not deal with classification
performance as studies dealing with the effect of different
scaling procedures on classification performance has already
been published (for example see Yang et al. 2015).
2 Methods
2.1 Data sets and raw data processing
2.1.1 Missing value imputation study
Four different non-targeted UHPLC-MS metabolomics
datasets were employed to assess six different missing
value imputation methods.
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2.1.1.1 Datasets
(1) Mouse serum from a study of ischemia following
stroke acquired in negative ion centroid mode. The
dataset consisted of 34 samples divided into five
different classes and reported 4435 metabolite fea-
tures. The m/z range was 100–1000 and the data
were acquired applying a UHPLC Accela system
coupled to an electrospray LTQ-Orbitrap Velos mass
spectrometer (Thermo Scientific, UK) applying a
method as previously described (Dunn et al. 2011).
(2) Placental tissue extract from a study of normal and
pre-eclamptic pregnancy as published previously
(Dunn et al. 2012). Data for 24 samples were
acquired in negative ion centroid mode with 3412
metabolite features. The m/z range was 100–1000
and data were acquired on a UHPLC-MS system
(Waters Acquity UHPLC system and Thermo Sci-
entific LTQ-Orbitrap XL).
(3) Human urine samples; these data are currently not
published. The dataset consisted of 48 samples
acquired in positive ion profile mode with 3823
metabolite features. The m/z range was 100–1000
and data were acquired on a UHPLC-MS system
(Thermo Scientific Dionex Ultimate 3000 UHPLC
system and Thermo Scientific Q-Exactive).
(4) Mammalian cellular extracts dataset; these data are
currently not published. The dataset consisted of 88
fibroblast samples acquired in positive ion profile
mode with 2008 metabolite features. The m/z range
was 100–1000 and data were acquired on a UHPLC-
MS system (Thermo Scientific Dionex Ultimate
3000 UHPLC system and Thermo Scientific
Q-Exactive).
2.1.1.2 XCMS processing The .RAW files produced were
converted to .mzML format applying ProteoWizard 2.1
(Kessner et al. 2008) followed by deconvolution and peak
alignment applying XCMS applying a previously described
method (Dunn et al. 2008a).
2.1.1.3 Metabolite feature filtering Firstly, missing value
imputation was performed for each feature that was not
detected in a single class but was detected in other classes.
Applying R, the missing values in the single class were
replaced by a value defined as the minimum peak area
reported in the data matrix multipled by 0.5. Subsequently,
features or samples containing more than 20 % missing
values across all classes were deleted (peak filtering).
2.1.1.4 Missing Value Imputation methods Normalisa-
tion by sum for each sample was applied (see
Sect. 2.1.2.3). Five different missing value imputation
methods were assessed:
(1) Small value replacement (SV): for every metabolite
feature the missing values were replaced by a value
half of the minimum peak intensity of the entire
dataset (Xia and Wishart 2011).
(2) Mean replacement (MN): for every metabolite
feature the missing values were replaced by the
mean of the specific metabolite across all samples
(Xia and Wishart 2011) (excluding the missing
values in the calculation).
(3) Median replacement (MD): for every metabolite
feature the missing values were replaced by the
median of the specific metabolite across all samples
(Xia and Wishart 2011) (excluding the missing
values in the calculation).
(4) K-nearest neighbour imputation (KNN): the missing
values are replaced by the average of the corre-
sponding (feature specific) non-missing values in the
k (here k = 10) closest features in terms of
Euclidean distance of the responses across all the
samples. Therefore a unique value is imputed for
every missing value in a feature instead of using the
same value multiple times as in approaches 1–3 (Xia
and Wishart 2011; Hrydziuszko and Viant 2012).
(5) Bayesian Principal Component Analysis replace-
ment (BPCA): the missing values are replaced by the
values obtained through principal component anal-
ysis regression with a Bayesian method. Therefore
every imputed missing value does not occur multiple
times neither across the samples nor across the
metabolite features (Hrydziuszko and Viant 2012;
Nyamundanda et al. 2010).
(6) Random Forest imputation (RF): missing values are
iteratively imputed using as a decisional criterion the
proximity matrix generated by a RF classification
computed across the total number of metabolites
(Breiman 2001).
All the computations were performed using built-in R
3.0.2 functions except KNN which was performed using the
package ‘‘impute’’, BPCA which was performed using the
package ‘‘pcaMethods’’(Stacklies et al. 2007) and RF which
was performed using the package ‘‘missForest’’. ‘‘impute’’
and ‘‘pcaMethod’’ packages are freely available in Biocon-
ductor (http://www.bioconductor.org/) while ‘‘missForest’’
is downloadable from the CRAN repository (https://cran.r-
project.org/). Multivariate imputation by chained equation
was not tested since it resulted in a computationally intense
method while Sangster’s method was not performed due to
lack of technical replicates, which is a common occurrence
in non-targeted metabolomics studies.
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2.1.1.5 Assessment of different MVI methods In order to
assess the performance of the different imputation methods
each of the datasets described in Sect. 2.1.1.1 was treated
as follows: only metabolite features (m/z-retention time
pairs) with no missing values were retained; next a series of
feature intensities in this data matrix were randomly
selected, their intensities re-classified as ‘missing values’,
until reaching a missing value frequency in the dataset of
10 %. Data were simulated as missing completely at ran-
dom (MCAR) because the Pearson correlation coefficients
did not show any relationship between m/z, response,
retention time and frequency of missing values. Next,
comparison of the original matrix (with no missing values)
to the modified matrix (with randomly introduced missing
values)—for each of the four datasets investigated—was
performed applying normalised root mean squared error
(NRMSE) for every imputation method. The root mean
squared error was calculated on the difference between
original and imputed values and normalised by the mean
value of the matrix.
2.1.1.6 Calculation of Pearson correlation coefficients For
each metabolite feature the m/z, retention time, mean
response and number of missing values were calculated.
Pearson correlation coefficients were calculated for (i) m/z
vs. number of missing values; (ii) retention time vs. number
of missing values, and (iii) mean response vs. number of
missing values.
2.1.2 Data processing study
2.1.2.1 Dataset A single UHPLC-MS dataset was used
to assess the effect of different combinations of processing
methods in relation to response and fold change. Human
serum was acquired in positive ion mode for 64 samples
(46 biological samples and 18 QC samples). The total
number of detected metabolite features was 3837. The m/z
range applied was 100-1000 and the data were acquired on
a Ultimate3000 UHPLC system coupled to a LTQ-FT Ultra
mass spectrometer (Thermo Scientific, UK). Data were
processed applying XCMS as defined in Sect. 2.1.1.2.
2.1.2.2 Construction of modified dataset We artificially
modified peak intensities to introduce known metabolic
differences between groups and this provided us with a
target for discovering these artificial peak intensities using
both univariate and multivariate statistics. The effects of
the processing steps on our ability to re-discover these
known metabolic differences were evaluated. The 46 bio-
logical samples were randomised into two classes with the
median fold change between class A and class B in the
range 0.8–1.2. Mann–Whitney U test defined no metabolite
features that were statistically significant (p\ 0.05). All
metabolite features were separated into three blocks based
on response (the mean response was calculated across all
features, the vector of the means was then ordered and split
into three sections with each section defined as 0–33 %
(low), 34–66 % (medium) and 67–100 % (high) of the
range of means). Thirty-two metabolite features in class A
were randomly chosen (applying sample() random function
in R) from each of the three blocks and multiplied by a
factor between 0.1 and 10 (0.1 to 2.0 in steps of 0.1 and
from 2.5 to 10.0 in steps of 0.5). This modified dataset was
applied for comparison of different processing methods. A
flow chart is available in SI2.
2.1.2.3 Normalisation methods The modified dataset was
normalised by sum or PQN.
• Normalisation by sum: each value in a row (sample) is
divided by the total sum of the row (sample) and
multiplied by 100; the unit is %.
• PQN: for every feature the mean response is calculated
across all QC samples. A reference vector is then
generated. The median between the reference vector
and every sample is computed obtaining a vector of
coefficients related to each sample. Each sample is then
divided by the median value of the vector of coeffi-
cients; this median value is different for each sample.
This method was adapted by Dieterle et al. (2006). Its
purpose is to take into account the concentration
changes of some metabolite features that affect limited
regions of the data.
Other normalisation methods requiring internal stan-
dards or technical replicates were not investigated because
the analytical samples contained no internal standard and
technical replicates were not acquired.
2.1.2.4 Missing Value Imputation methods Six missing
value imputation methods were assessed as defined in
Sect. 2.1.1.4.
2.1.2.5 Transformation methods Three different trans-
formation methods (van den Berg et al. 2006) were
assessed:
• Generalised logarithm (glog) (Parsons et al. 2007):
every value is transformed according to the equation
z ¼ ln yþ
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
y2 þ k
p
 
where y is the untransformed value, z is the trans-
formed value and k is a parameter which is iteratively
computed (from a series of technical replicates, in this
case QC samples) in order to minimise the variation;
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• Natural logarithm (nlog): every value is transformed in
the corresponding natural logarithm;
• Inverse hyperbolic sine (IHS)(Mak et al. 2014): every
value is transformed according to the equation:
z ¼ lnðyþ
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
y2 þ 1Þ
p
 
2.1.2.6 Scaling methods Four different (peak-wise)
scaling approaches were assessed:
• Autoscaling: every peak is mean centered and divided
by the standard deviation of the column. This treatment
makes the standard deviation of each metabolite equal
to 1. Autoscaling, along with range scaling, is not
affected by the feature abundance (Jackson 1991).
• Pareto scaling: every peak is mean centered and divided
by the square root of the standard deviation of the
column (Eriksson et al. 1999). The influence of noise
variables on the multivariate model is reduced com-
pared to autoscaling.
• Range scaling: every peak is mean centered and divided
by the numerical difference between the maximum and
minimum values of the column (Smilde et al. 2005).
• Vast scaling: every peak is autoscaled and divided by
the coefficient of variation. It is particularly suited for
metabolites bearing small fold changes (Keun et al.
2003).
All processing was carried out using built-in R 3.0.2
functions. The source code for many of the steps applied
can be found in the Galaxy-M repository https://github.
com/Viant-Metabolomics/Galaxy-M. All possible permu-
tations of normalisation, missing values imputation, trans-
formation and scaling (see SI3) were explored and applied
on the modified dataset described.
2.1.2.7 Univariate and multivariate data analysis The
Shapiro–Wilk test of normality was applied for all
metabolite features to assess whether the data were nor-
mally distributed (the null hypothesis is that the distribu-
tion does not differ from a normal distribution; p\ 0.05
defines that the distribution is not normal). This was per-
formed on data before any normalisation, MVI, scaling and
transformation and after normalisation, MVI, scaling and
transformation.
Univariate analysis was performed applying the Mann–
Whitney U test and Students t test (non-parametric and
parametric, respectively) between class A and class B. Data
for QC samples were removed from the datasets prior to
univariate analysis. The Benjamini–Hochberg (Benjamini
and Hochberg 1995) false discovery correction for multiple
comparisons was applied afterwards.
Multivariate analysis was performed applying Principal
Component Analysis (PCA) and Partial Least Squares-
Discriminant Analysis (PLS-DA), QC samples were
excluded from the analysis prior to PLS-DA analysis. The
R packages mixOmics and pcaMethods were used for this
purpose. Further statistical analysis consisted of t-test or
Mann-Whitney U-test performed on the PCA scores in
order to identify statistically significant clustering patterns.
Prior to these procedures a Shapiro–Wilk test was carried
out to assess the normality of the score matrix in order to
apply parametric or non-parametric statistics. For PLS-DA,
the classification performance was identified through the
application of cross-validation and calculation of R2 and Q2
values. The optimal number of components was evaluated
applying a tenfold cross validation.
Analysis of the univariate outcome The Mann–Whitney
U-test and t-test between class A and B were calculated for
each combination of normalisation, missing value impu-
tation, transformation and scaling methods (a total of 280
permutations). The total number of significant peaks
(q\ 0.05) and the number of the 96 metabolite features
(with deliberately modified intensities) showing statistical
significance were both reported. The number of false pos-
itive statistically significant metabolite features was cal-
culated by subtracting the number of intensity-modified
significant peaks from the total number of significant
peaks. Here, by ‘‘false positive’’, we indicate peaks that
were incorrectly marked as significantly different; the
intensities of these peaks were not altered, hence bearing a
fold change between classes in the range 0.8 and 1.2 and
not being statistically significant in the original dataset.
Analysis of the multivariate outcome Following PCA
and PLS-DA analysis all the metabolite features that were
intensity-modified were ranked according to their absolute
loading value on PC1, PC2 and a combination of PC1 and
PC2, and on latent variable 1, latent variable 2 and a
combination of both for PLS-DA. The range of ranks was
reported for the top ten highest ranked metabolite features.
The permutations (the 280 different combinations of
normalisation, MVI, scaling and transformation) were
sorted including the entries having a fold change effect and
lacking an abundance effect in PC1 and PC2. These entries
were sorted according to the p-value (low to high) pro-
duced by the PC1 score plot separation between classes and
according to the % variance contribution for PC1 ? PC2
as a second level. For PLS-DA the permutations were
sorted by R2 value (high to low) and differences between
R2 and Q2 of less than 0.20 (low to high).
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3 Results and discussion
3.1 Missing value imputation study
The percentage of missing values was calculated and an
assessment to determine whether missing values were
correlated with m/z, retention time or response was per-
formed for four different datasets (mouse serum, human
urine, placental tissue, mammalian cell extract) acquired
applying two different analytical methods (reversed phase
and HILIC) and three different UHPLC-MS platforms
(Accela UHPLC coupled to LTQ-Orbitrap Velos, Ulti-
mate3000 coupled to LTQ-FT Ultra, and Ultimate3000
coupled to Q Exactive). Table 1 defines the percentage
missing values and Pearson correlation coefficients for
each dataset. In this paper we define a metabolite feature as
a m/z-retention time pair with a single metabolite typically
being detected as more than one metabolite feature.
The percentage of missing values ranged from 8.7 to
15.0 % before filtering and 2.8 to 5.0 % after filtering. A
relatively strict filter was applied, where any metabolite
feature with[20 % missing values was removed from the
dataset. Correlations between m/z and the number of
missing values, retention time and the number of missing
values, and intensity and the number of missing values
were close to zero. These results show that the number of
missing values is not correlated with m/z, retention time or
response across the complete data for each dataset. The
structure of missing values in relation to m/z, retention time
or response is shown in SI4. For two of four datasets
(mammalian cell extract and placental tissue) some struc-
ture is observed when investigating missing values and
retention time. Here a lack of missing values is observed
around 150–250 s, though the number of metabolite fea-
tures detected in this retention time range is lower than in
any other 100 s range. We therefore assume that missing
values occur at random across the dataset and are primarily
a result of peak picking software not reporting metabolite
peaks; i.e. the peaks are missing because of the genuine
absence of metabolites or because they are present but at a
concentration lower than the analytical method’s limit of
detection.
To assess six different MVI methods (SV, MN, MD,
KNN, BPCA and RF) the four datasets discussed above
were filtered to remove metabolite features which con-
tained one or more missing value. Missing values were
then randomly introduced into each of the datasets to a
frequency of 10 %. This frequency of 10 % was chosen as
it was equivalent to the highest missing value frequency in
six further datasets collected with different instrument
manufacturers (4 datasets collected on Agilent Q-TOF
systems and 2 datasets collected on Waters Q-TOF sys-
tems) which presented a distribution of missing values after
peak filtering of 2.3–10.5 %. These datasets are detailed in
SI5. The same range for the four datasets discussed above
was 2.8–5.0 %. The similarity between the original matrix
with no missing values and the modified matrix containing
imputed missing values was calculated applying nor-
malised root mean squared error (NRMSE) for each of the
six missing value imputation methods. The results are
shown in Table 2.
The results show that small value replacement, with the
largest NRMSE values, is the least optimal method for
missing value imputation. This is expected as small value
imputation would be expected to work when missing val-
ues are related to low responses; however Pearson corre-
lation analysis showed no correlation between response and
missing values. RF achieved the lowest NRMSE values in
all four datasets with marked improvement compared to all
the other imputation methods. KNN and BPCA also per-
formed quite well with KNN slightly out performing BPCA
for placental tissue and mammalian cell extracts datasets
while BPCA performing similarly to KNN in mouse serum
and human urine datasets. Overall, RF seems to be the best
imputation method in all cases tested. The major drawback
of RF is the computational time which was typically
Table 1 Summary of the percentage of missing values present in four datasets and the correlation of missing values observed with m/z, retention
time and response
Dataset Mouse serum Placental tissue Human urine Mammalian cell extract
Metabolite features before filtering 4435 3412 3823 2008
Missing values before filtering (%) 15.0 10.2 14.0 8.7
Metabolite features after filtering 2996 2622 2684 1598
Missing values after filtering (%) 4.5 2.8 5.0 3.7
Pearson coefficient (missing values vs. mean abundance) -0.05 -0.12 -0.05 -0.08
Pearson coefficient (missing values vs. m/z values) 0.07 -0.02 0.30 0.35
Pearson coefficient (missing values vs. retention time) 0.02 -0.11 0.03 -0.07
Filtering was performed as defined in Sect. 2.1.1.3
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greater than 15 min in the study reported here. KNN and
BPCA, despite achieving a worse performance compared
to RF require considerably faster computation times. The
use of MN and MD showed comparable results for pla-
cental tissue and mammalian cell extract datasets while
they tended to be less efficient in the mouse serum and
human urine datasets. Conclusively, it is recommended that
RF is applied for missing value imputation for multivariate
analysis, consistent with the finding for GC–MS metabo-
lomics data (Gromski et al. 2014). We do not recommend
the use of MVI for univariate analysis because of the
potential to change the distribution within each class. Even
though RF provided the smallest NRMSE, the values were
not zero and therefore indicative of a ‘perfect’ missing
value algorithm.
3.2 Data processing study
A sample set containing 46 biological samples analysed in
positive ion mode applying UHPLC–MS was randomised
into two classes containing 22 (class A) and 24 samples
(class B); the R function applied does not provide the same
number of samples in each class. Univariate and multi-
variate analysis was performed prior to any dataset modi-
fication. The Mann–Whitney U-test did not identify any
statistically significant peaks (p\ 0.05) and PCA reported
the samples as randomly scattered across the scores plot for
PC1-3 (data not shown). PLS-DA did not report a cross-
validated model. These results show that no separation of
classes A and B was observed before the dataset was
modified (data not shown).
After all metabolite features were ranked according to
response and grouped into three classes (low, medium and
high response), 32 metabolite features in each class were
randomly chosen. For each class the metabolite features
were randomised into a rank order and then the response
was multiplied by a factor between 0.1 and 10. Following
this process there were 7.8 % of all reported values which
were defined as missing values and 65.3 % of features were
shown to have at least one sample with a missing value.
The normality of the resulting dataset was assessed
applying the Shapiro–Wilk test showing a high percentage
of features not following a normal distribution before and
after log transformation as shown in SI6.
Consequently the modified dataset was analysed apply-
ing non-parametric univariate (Mann–Whitney U test) as
well as multivariate (PCA, PLS-DA) methods following
different permutations of normalisation, missing value
imputation, transformation and scaling methods being
applied. Two normalisation (PQN and SUM), seven miss-
ing value imputation (none, SV, MN, MD, KNN, BPCA
and RF), four transformation (none, glog, ihs, nlog) and
five scaling (none, autoscaling, Pareto scaling, range scal-
ing and Vast scaling) methods were assessed. 280 different
permutations were assessed as shown in SI3.
3.2.1 Univariate analysis
The results for all the permutations are shown in SI7 and a
summary presented in Table 3, where each unique set of
results is shown and where one row can represent multiple
permutations; for example, ‘all’ defines that all of the
methods applied produced the same result. The results
show that no permutation of data processing methods is
ideal, as no method led to 96 true positive (statistically
significant) features and zero false positives. Three per-
mutations provided 81 true positive and zero false positive
results. Two of these applied PQN normalisation and one
SUM normalisation. Interestingly, two permutations
applied RF missing value imputations and one did not
apply any missing value imputation. Although RF missing
value imputation provided the best results in this compar-
ison we still recommend that RF is not applied for uni-
variate analysis. This is because the NRMSE values
reported in 3.1 were not zero (indicative of a ‘perfect’
missing value algorithm) and therefore the data structure is
still altered.
The normalisation method had a minimal effect, with
PQN and SUM reporting 81 and 80 statistically significant
metabolites. KNN and BPCA missing value imputation
Table 2 Normalised root mean squared errors (NRMSE) for four datasets for comparison of six different missing value imputation methods
MVI method Mouse serum Placental tissue Human urine Mammalian cell extract
Small value replacement 9.99 3.64 7.66 5.53
Mean 1.82 0.66 1.47 1.01
Median 1.60 0.68 1.49 1.01
K-nearest neighbours 1.29 0.58 1.44 0.54
Bayesian principal components analysis 1.30 0.62 1.49 1.12
Random forest 0.75 0.45 1.16 0.37
An NRMSE close to zero implies the imputation algorithm has most correctly predicted the missing values
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methods and all scaling methods resulted in false positives
for both normalisation processes and are not fully appro-
priate to apply for univariate analysis. Sixteen and fifteen
metabolites were not reported as statistically significant for
the SUM and PQN normalisation methods. The metabolites
reported as not statistically significant were primarily those
with a fold change in the range 0.8–1.2 for all three
response classes (low, median, high). This shows that the
inter-subject variation in the dataset is greater than the
variation associated with the modifications performed for
these 15 metabolite features. At fold changes less than 0.8
and greater than 1.2 there was no significant effect of fold
change or response on the p-values reported for any
metabolite within a single permutation. Our results show
that the use of SUM or PQN normalisation with no MVI
and no scaling or transformation should be applied for
univariate analysis. It should be noted that SUM normali-
sation cannot deal well with large differences in a few
metabolites in large datasets and so PQN normalisation is
recommended (Kohl et al. 2012). This conclusion should
not be interpreted as a rigid rule, instead it offers guidance
to the user. Indeed the treatment performed for univariate
analysis is heavily affected by the purpose of the study.
The results we report here are somewhat consistent with
the conclusions reported by Hrydziuszko et al.4 for DIMS
data, though this reported study did not assess RF missing
value imputation.
3.2.1.1 Students t test A similar investigation was per-
formed as for Sect. 3.2.1 with the single difference being
the use of the parametric students t test. Many research
groups apply parametric statistical tests and there is a
general assumption that log transformations will convert
data into a normal distribution, which we investigated here.
As defined in SI6, the percentage of metabolite features not
demonstrating a normal distribution with no glog trans-
formation ranged from 39.6 to 41.6 % with glog transfor-
mation reducing the number of metabolite features
showing a non-normal distribution by less than 12 %. In
conclusion, although log transformations increase the
number of features which are normally distributed, the
percentage of features which are not normally distributed is
still high (greater than 50 %). To evaluate the use of the
Students t test and Mann–Whitney U test we applied the
Students t-test and compared the results to those obtained
for the Mann–Whitney U test (see Sect. 3.2.1). The data
applying Students t test are shown in SI8. The manipulated
features which were not statistically significant were again
the ones multiplied by a factor ranging between 0.8 and 1.2
apart from a few exceptions. As a general conclusion, the
same number of true positives and false positives were
reported when applying both the parametric and non-
parametric statistical methods.
3.2.2 Multivariate analysis
3.2.2.1 PCA The dataset was applied to assess all 280
permutations of normalisation, missing value imputation,
transformation and scaling followed by PCA analysis. The
purpose of this study was to identify data processing
methods driven by fold change but not abundance (as is
applied in many but not all metabolomics studies). Indeed
Table 3 Summary of the number of the 96 modified metabolite features defined as statistically significant (q\ 0.05) and the number of
metabolite features falsely reported as statistically significant (q\ 0.05) for all of the different data processing methods applied
Normalisation Missing value imputation Transformation Scaling True positive results False positive results
PQN/SUM RF All All 81 0
PQN None All All 81 0
PQN MN/MD All All 80 0
SUM None All All 80 0
SUM MN/MD/SV All All 79 0
PQN SV All All 77 0
SUM BPCA glog Range/Autoscaling/VAST 81 1
SUM KNN All All 81 3
SUM BPCA All None/Pareto 81 3
PQN KNN All All 82 5
PQN BPCA All All 82 6
All defines that all methods provided the same result. The closer the number of significant modified features to 96 implies the data processing has
performed more ideally
PQN probabilistic quotient normalization, RF random forest, MN mean, MD median; SV small value, KNN k-nearest neighbour, BPCA Bayesian
principal components analysis, glog generalised log
Non-targeted UHPLC-MS metabolomic data processing methods: a comparative investigation… Page 9 of 14  93 
123
such an outcome is desirable since it is rather common for
metabolomics datasets to present the majority of detected
metabolites with relatively low abundance. Here for
example, 2843 features out of 3837 were present in the
25th quartile thus highlighting the potential importance of
low abundance peaks. The results are shown in SI9 and the
top 10 permutations showing (1) separations related to fold
change only; (2) the highest variance observed in
PC1 ? PC2 and (3) the most statistically significant dif-
ferences in PC1 are shown in Table 4. The first ten ranked
permutations all applied RF for missing value imputation
and either SUM or PQN normalisation. The first five
ranked permutations showing the highest statistical sig-
nificance all applied no scaling and applied glog, nlog or
IHS transformations. SUM normalisation, RF missing
value imputation, glog transformation and no scaling
contributed 100 % variance in PC1 ? PC2 and the most
statistically significant p-value for PC1. While the combi-
nation of SUM or PQN normalisation and no missing value
imputation may be addressed as a solution, it must be
remarked that the PCA computation on datasets including
missing values is slower compared to the calculation on
imputed datasets because of the use of the NIPALS algo-
rithm which imputes missing values; furthermore the
evaluation of PLS-DA models from datasets containing
missing values often encounters several technical issues
(e.g. cross-validation methods do not work well when
missing values are present). PQN, despite achieving lower
p-values compared to SUM permutations, still produces
good separation across both principal components. As
discussed above, SUM normalisation cannot deal well with
large differences in a few metabolites in large datasets and
so PQN normalisation is recommended (Kohl et al. 2012).
It is notable that once a transformation is performed scaling
is not necessary to obtain PCA models that show the most
statistically significant p-value for PC1. Examples of PCA
scores plots for a method which is appropriate and is not
appropriate is shown in Fig. 1.
3.2.2.2 PLS-DA The dataset was applied to assess all 280
permutations of normalisation, missing value imputation,
transformation and scaling followed by PLS-DA analysis.
The results are shown in SI10 and the top eight ranked
permutations based on the highest R2 value with a R2 - Q2
difference of less than 0.20 are shown in Table 5. The
permutations where higher R2 values were observed show
no distinct trend. There is no significant advantage obtained
by applying SUM normalisation or PQN normalisation.
KNN and BPCA missing value imputation operate more
effectively than other imputation methods, including RF.
The highest ranked permutations with the smallest R2 - Q2
difference were (1) PQN normalisation, BPCA MVI, glog
transformation and range scaling and (2) SUM or PQN
normalisation, KNN MVI, glog transformation and no
scaling. Importantly, the optimal data processing methods
for PLS-DA are different to the optimal methods for PCA.
Examples of PLS-DA scores plots for a method which is
appropriate and is not appropriate is shown in Fig. 1.
3.3 Data processing workflow
Applying the conclusions constructed from the data
reported in this paper we have constructed a standardised
data processing workflow for all mammalian sample
datasets we study. This workflow is described in SI11 and
includes peak picking, quality control, metabolite annota-
tion, metabolite feature filtering, missing value imputation,
normalisation and transformation processes applicable for
both univariate and multivariate (PCA and PLS-DA) data
analysis methods.
Table 4 Summary of the top ten permutations according to p-value achieved for PC1 scores values
Normalisation MVI Transformation Scaling Variance (PC1; %) Variance (PC2; %) P-value (PC1)
SUM RF glog None 42.7 39.3 4.82E-12
SUM RF nlog None 44.7 28.6 1.66E-08
PQN RF glog None 43.9 28.7 1.66E-08
PQN RF IHS None 44.7 28.6 1.83E-07
PQN RF nlog None 44.7 28.6 1.83E-07
SUM RF glog Pareto 41.5 31.2 0.01601
SUM RF nlog Pareto 43.2 30.4 0.02768
PQN RF nlog Pareto 42.1 31.2 0.02934
PQN RF IHS Pareto 42.1 31.2 0.02934
PQN RF glog Pareto 41.7 31.5 0.03482
The greater the combined percentage variance for PC1 and PC2 and the lowest p-values for PC1 and PC2 implies the data processing has
performed more ideally
PQN probabilistic quotient normalization, RF random forest, glog generalised log, nlog normal log, IHS inverse hyperbolic sine
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4 Concluding remarks
This study has highlighted important relationships between
normalisation, missing value imputation, transformation and
scaling methods and how these should be applied prior to
univariate and multivariate analysis. Once data is filtered,
missing values are not correlated with m/z, retention time or
response; instead missing values are randomly observed in
datasets and are potentially a cause of errors in peak picking
software. As has been reported previously, many missing
value imputation methods negatively influence univariate
analysis outcomes though we have shown here that the RF
Fig. 1 Examples of PCA and PLS-DA scores plots for acceptable and
not acceptable data processing methods a PCA scores plot for data
processed applying RF missing value imputation, SUM normalisa-
tion, glog transformation and no scaling which is defined as an
acceptable method; 100 % variance accounted for in PC1 and 2, PC1
p = 4.8E-12; b PCA scores plot for data processed applying small
value missing value imputation, SUM normalisation, glog transfor-
mation and no scaling which is defined as not an acceptable method;
25.7 % variance accounted for in PC1 and 2, PC1 p = 1.8E-7; c PLS-
DA scores plot for data processed applying KNN missing value
imputation, PQN normalisation, glog transformation and no scaling
which is defined as an acceptable method; R2 = 0.61, Q2 = 0.46;
d PLS-DA scores plot for data processed applying small value
missing value imputation, SUM normalisation, glog transformation
and no scaling which is defined as not an acceptable method;
R2 = 0.42, Q2 = 0.31. Red circles = Class A; black crosses = Class
B; Green triangles = QC sample (Color figure online)
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missing value imputationmethod performs equivalently to no
missing value imputation. We recommend that no missing
value imputation, no scaling and no transformations are used
prior to univariate statistical analysis. When using SUM or
PQN normalisation with RF missing value imputation or no
missing value imputation and no other data processing
methods applied, a high number of metabolite features were
determined to be statistically significant while the false pos-
itive rate was 0 %. Normalisation, missing value imputation,
scaling and transformation all impacted on the results
observed for PCA and PLS-DA; datasets treated differently
resulted in diverse clustering trends. It has been found for
PCA that SUM or PQN normalisation, in combination with
RF missing value imputation, glog transformation, and no
scaling highlights the metabolite features with a significant
fold change between classes regardless of the metabolite
feature response with the highest percentage variance
explained in PC1 and PC2 and with the most statistically
significant p-value for PC1.We recommend this combination
of data processingmethods for PCA including the use of PQN
rather than SUM normalisation because SUM normalisation
has been shown to not be robust when a small number of
metabolites with a large fold change is present. RF was
reported as being the most valid missing value imputation
method for PCA. For PLS-DA, KNN and BPCA missing
value imputation operate more effectively than other impu-
tation methods, including RF. The highest ranked permuta-
tions with the smallest R2 - Q2 difference were (1) PQN
normalisation, BPCA MVI, glog transformation and range
scaling and (2) SUM normalisation, KNN MVI, glog trans-
formation and no scaling.We recommend the second of these
permutations for PLS-DA analysis. Therefore we conclude
that the best data processing procedures to apply when per-
forming UHPLC–MS driven non-targeted metabolomics are
different for univariate, PCA and PLS-DA methods when
searching for the biologically important metabolite features
independent of response. Importantly, our evaluation is based
on classification and the use of Pareto scaling is recom-
mended when determining the metabolites of biological
significance in multivariate analysis.
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